| Primary |
| Iron Overload |
28.5% |
| Blood Iron Increased |
13.8% |
| Haemosiderosis |
11.0% |
| Myelodysplastic Syndrome |
10.4% |
| Thalassaemia Beta |
7.2% |
| Thalassaemia |
5.5% |
| Haemochromatosis |
4.3% |
| Chelation Therapy |
3.2% |
| Sickle Cell Anaemia |
2.6% |
| Serum Ferritin Increased |
2.0% |
| Neutropenia |
1.7% |
| Diabetes Mellitus |
1.4% |
| Hypertension |
1.4% |
| Hereditary Haemochromatosis |
1.2% |
| Liver Disorder |
1.2% |
| Transfusion |
1.2% |
| Anaemia Prophylaxis |
0.9% |
| Aplasia Pure Red Cell |
0.9% |
| Aplastic Anaemia |
0.9% |
| Blood Aluminium Increased |
0.9% |
|
| Vomiting |
13.4% |
| Renal Failure |
8.4% |
| Visual Acuity Reduced |
8.4% |
| Pyrexia |
7.6% |
| Treatment Noncompliance |
7.6% |
| Serum Ferritin Increased |
6.7% |
| Death |
5.0% |
| Vulvovaginal Mycotic Infection |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Transaminases Increased |
4.2% |
| Cardiac Failure |
3.4% |
| Pancreatitis Acute |
3.4% |
| Vasculitis |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Blindness |
2.5% |
| Cardiac Siderosis |
2.5% |
| Eosinophilic Pneumonia |
2.5% |
| Gamma-glutamyltransferase Increased |
2.5% |
| General Physical Health Deterioration |
2.5% |
| Liver Function Test Abnormal |
2.5% |
|
| Secondary |
| Iron Overload |
27.5% |
| Blood Iron Increased |
22.6% |
| Myelodysplastic Syndrome |
7.2% |
| Thalassaemia Beta |
6.2% |
| Serum Ferritin Increased |
5.3% |
| Aplastic Anaemia |
4.2% |
| Thalassaemia |
4.2% |
| Haemosiderosis |
3.1% |
| Nausea |
2.9% |
| Haemochromatosis |
2.2% |
| Headache |
2.2% |
| Dyspepsia |
2.0% |
| Pain |
2.0% |
| Arrhythmia |
1.4% |
| Hypersensitivity |
1.4% |
| Diabetes Mellitus |
1.3% |
| Sickle Cell Anaemia |
1.3% |
| Cardiac Failure |
1.1% |
| Pyrexia |
1.1% |
| Paroxysmal Nocturnal Haemoglobinuria |
0.9% |
|
| Vulvovaginal Mycotic Infection |
17.0% |
| Vomiting |
14.5% |
| Serum Ferritin Increased |
9.1% |
| Vulvovaginal Pruritus |
6.7% |
| Treatment Noncompliance |
6.1% |
| Staphylococcal Sepsis |
5.5% |
| Sickle Cell Anaemia With Crisis |
4.8% |
| White Blood Cell Count Decreased |
4.2% |
| Pyrexia |
3.6% |
| Visual Acuity Reduced |
3.6% |
| Infection |
3.0% |
| Renal Impairment |
3.0% |
| Vision Blurred |
3.0% |
| Weight Decreased |
3.0% |
| Sepsis |
2.4% |
| Ultrasound Abdomen Abnormal |
2.4% |
| White Blood Cell Count Increased |
2.4% |
| Asthenia |
1.8% |
| Pulmonary Hypertension |
1.8% |
| Rash |
1.8% |
|
| Concomitant |
| Iron Overload |
21.8% |
| Myelodysplastic Syndrome |
18.5% |
| Prophylaxis |
13.4% |
| Aplastic Anaemia |
10.6% |
| Drug Use For Unknown Indication |
8.5% |
| Product Used For Unknown Indication |
6.6% |
| Paroxysmal Nocturnal Haemoglobinuria |
2.3% |
| Diabetes Mellitus |
1.9% |
| Thalassaemia Beta |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Cardiac Failure Congestive |
1.4% |
| Pain |
1.4% |
| Gastritis Prophylaxis |
1.4% |
| Myelofibrosis |
1.4% |
| Hypothyroidism |
1.3% |
| Hypertension |
1.2% |
| Asthma |
1.1% |
| Chronic Myeloid Leukaemia |
1.1% |
| Multiple Myeloma |
1.1% |
| Sickle Cell Anaemia |
1.1% |
|
| Renal Impairment |
9.4% |
| White Blood Cell Count Decreased |
9.4% |
| Vomiting |
8.2% |
| Serum Ferritin Increased |
6.9% |
| White Blood Cell Count Increased |
6.9% |
| Weight Decreased |
6.3% |
| Infection |
5.7% |
| Pneumonia |
5.7% |
| Pyrexia |
5.0% |
| Urinary Tract Infection |
5.0% |
| Death |
3.8% |
| Gastrointestinal Haemorrhage |
3.8% |
| Hepatic Function Abnormal |
3.8% |
| Treatment Noncompliance |
3.8% |
| Pancytopenia |
3.1% |
| Renal Disorder |
3.1% |
| Blood Creatinine Increased |
2.5% |
| Blood Urea Increased |
2.5% |
| Cataract |
2.5% |
| Fall |
2.5% |
|
